Polymorphic variants in the efflux transporter gene ABCB1 may predict fluorouracil, adriamycin, and cytoxan (FAC) regimen’s myelotoxicity, except for leukopenia [31]. This evidence concerns the gene ABCB1 and Decreased total leukocyte count.